Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc. (TRDA) Stock Ticker

NASDAQ: TRDA · Healthcare · Biotechnology
$6.16-0.96%
USD · as of 2026-09-28 · market cap $239.1M
Open TRDA in TickrDownload for iPhone

TRDA right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±12.1%
Options expect by Oct 29±25.0%
Priced in for Nov 5 earnings±27.7%
IV rank (30-day)53% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full TRDA picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on TRDA
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.

TRDA stock facts

Ticker symbolTRDA
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$239.1M
CEODipal Doshi
Employees152
HeadquartersBoston, MA, US
IPO date2021-10-29
Websitewww.entradatx.com

What you can see for TRDA on Tickr

Live TRDA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TRDA report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Entrada Therapeutics, Inc.?

The ticker symbol for Entrada Therapeutics, Inc. is TRDA, listed on the NASDAQ Global Market.

What is TRDA?

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product…

HomeExploreMarketLists
All pages